⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NRSNW News

NeuroSense Therapeutics Ltd. Warrant

NeuroSense Announces Statistically Significant 65% Reduction in Risk of Death and Greater than 14-Month Median Survival Benefit with PrimeC in ALS